Market Overview

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Rockwell Medical, Inc. Investors


LOS ANGELES, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") announces that it has commenced an investigation on behalf of Rockwell Medical, Inc. ("Rockwell" or the "Company) investors concerning the Company and its officers' possible violations of federal securities laws. 

If you are a shareholder who suffered a loss, click here to participate.

On June 27, 2018, Rockwell announced the resignation of its auditor, who claimed among other things, that the estimated reserves in Rockwell's Form 10-Q for the period ended March 31, 2018 were misstated  and have not been  corrected.

On this news, shares of Rockwell fell $0.85, or over 16%, to close at $4.41 on June  28, 2018, thereby damaging investors.

Follow us for updates on Twitter:

If you purchased Rockwell securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to, or visit our website at If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224

GPM Logo.jpg

View Comments and Join the Discussion!